Literature DB >> 27530354

Cannabidiolic acid-mediated selective down-regulation of c-fos in highly aggressive breast cancer MDA-MB-231 cells: possible involvement of its down-regulation in the abrogation of aggressiveness.

Shuso Takeda1,2, Taichi Himeno2, Kazuhiro Kakizoe2, Hiroyuki Okazaki2, Tomoko Okada3, Kazuhito Watanabe4, Hironori Aramaki5,6.   

Abstract

The physiological activities of cannabidiolic acid (CBDA), a component of fiber-type cannabis plants, have been demonstrated and include its function as a protector against external invasion by inducing cannabinoid-mediated necrosis (Shoyama et al., Plant Signal Behav 3:1111-1112, 2008). The biological activities of CBDA have been attracting increasing attention. We previously identified CBDA as an inhibitor of the migration of MDA-MB-231 cells, a widely used human breast cancer cell line in cancer biology, due to its highly aggressive nature. The chemical inhibition and down-regulation of cyclooxygenase-2 (COX-2), the expression of which has been detected in ~40 % of human invasive breast cancers, are suggested to be involved in the CBDA-mediated abrogation of cell migration. However, the molecular mechanism(s) responsible for the CBDA-induced down-regulation of COX-2 in MDA-MB-231 cells have not yet been elucidated. In the present study, we describe a possible mechanism by which CBDA abrogates the expression of COX-2 via the selective down-regulation of c-fos, one component of the activator protein-1 (AP-1) dimer complex, a transcription factor for the positive regulation of the COX-2 gene.

Entities:  

Keywords:  Cannabidiolic acid; Cyclooxygenase-2; Fiber-type cannabis plant; MDA-MB-231 cells; c-fos

Mesh:

Substances:

Year:  2016        PMID: 27530354     DOI: 10.1007/s11418-016-1030-0

Source DB:  PubMed          Journal:  J Nat Med        ISSN: 1340-3443            Impact factor:   2.343


  25 in total

1.  COX-2 inhibitor celecoxib suppresses tumor growth and lung metastasis of a murine mammary cancer.

Authors:  Ryoji Yoshinaka; Masa-Aki Shibata; Junji Morimoto; Nobuhiko Tanigawa; Yoshinori Otsuki
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

Review 2.  Phytocannabinoids in Cannabis sativa: recent studies on biosynthetic enzymes.

Authors:  Futoshi Taura; Supaart Sirikantaramas; Yoshinari Shoyama; Yukihiro Shoyama; Satoshi Morimoto
Journal:  Chem Biodivers       Date:  2007-08       Impact factor: 2.408

Review 3.  Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb.

Authors:  Angelo A Izzo; Francesca Borrelli; Raffaele Capasso; Vincenzo Di Marzo; Raphael Mechoulam
Journal:  Trends Pharmacol Sci       Date:  2009-09-02       Impact factor: 14.819

4.  Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

Authors:  Zahida Qamri; Anju Preet; Mohd W Nasser; Caroline E Bass; Gustavo Leone; Sanford H Barsky; Ramesh K Ganju
Journal:  Mol Cancer Ther       Date:  2009-11-03       Impact factor: 6.261

5.  Tetrahydrocannabinolic acid, a genuine substance of tetrahydrocannabinol.

Authors:  T Yamauchi; Y Shoyama; H Aramaki; T Azuma; I Nishioka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1967-07       Impact factor: 1.645

6.  Inhibition of activator protein 1 activity and neoplastic transformation by aspirin.

Authors:  Z Dong; C Huang; R E Brown; W Y Ma
Journal:  J Biol Chem       Date:  1997-04-11       Impact factor: 5.157

7.  Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells.

Authors:  J F Schmedtje; Y S Ji; W L Liu; R N DuBois; M S Runge
Journal:  J Biol Chem       Date:  1997-01-03       Impact factor: 5.157

8.  Δ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ).

Authors:  Shuso Takeda; Kazutaka Yoshida; Hajime Nishimura; Mari Harada; Shunsuke Okajima; Hiroko Miyoshi; Yoshiko Okamoto; Toshiaki Amamoto; Kazuhito Watanabe; Curtis J Omiecinski; Hironori Aramaki
Journal:  Chem Res Toxicol       Date:  2013-06-11       Impact factor: 3.739

9.  Inhibition of NF-kappa B by sodium salicylate and aspirin.

Authors:  E Kopp; S Ghosh
Journal:  Science       Date:  1994-08-12       Impact factor: 47.728

10.  Cannabidiolic acid as a selective cyclooxygenase-2 inhibitory component in cannabis.

Authors:  Shuso Takeda; Koichiro Misawa; Ikuo Yamamoto; Kazuhito Watanabe
Journal:  Drug Metab Dispos       Date:  2008-06-12       Impact factor: 3.922

View more
  1 in total

1.  Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats.

Authors:  Roger G Pertwee; Erin M Rock; Kelsey Guenther; Cheryl L Limebeer; Lesley A Stevenson; Christeene Haj; Reem Smoum; Linda A Parker; Raphael Mechoulam
Journal:  Br J Pharmacol       Date:  2017-12-05       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.